Skip to main navigation
  • Home
  • Search
  • We Are Vertex
    • We Are Vertex
    • Leadership
    • Board of Directors
    • Voices of Vertex
    • Collaborations & Partnering
    • Innovation Programs
    • Awards
    • Stories & Updates
      • Jeffrey Leiden, Chairman, President & Chief Executive Officer
    • Locations
    • Contact Us
      • Contact Us - For Patients
      • Contact Us - For Healthcare Providers
  • Pipeline & Medicines
    • Pipeline & Medicines
    • Our Approved Medicines
    • Guidance & Patient Support (U.S. Only)
    • Investigational Medicines (Pipeline)
    • Clinical Trials
    • Expanded Access
    • Become a Vertex Investigator
    • Independent Research
  • All In For CF
    • All In For CF
    • Understanding CF
    • Voices of CF
    • Our Advances in CF
    • Vertex in the CF Community
    • CF Community Support
  • Giving Back
    • Giving Back
    • Our STEM Program
    • Volunteer Programs
    • Grants & Funding Opportunities
    • Cystic Fibrosis Programs
    • The Vertex Foundation
  • Working Here
    • Working Here
    • Join Our Team
    • Employee Benefits
    • Rewards & Recognition
    • Career Development
    • University Relations
    • Diversity & Inclusion
  • Investors
  • Contact Us
  • Press Releases
  • Home
  • Search
  • We Are Vertex
    • We Are Vertex
    • Leadership
    • Board of Directors
    • Voices of Vertex
    • Collaborations & Partnering
    • Innovation Programs
    • Awards
    • Stories & Updates
      • Jeffrey Leiden, Chairman, President & Chief Executive Officer
    • Locations
    • Contact Us
  • Pipeline & Medicines
    • Pipeline & Medicines
    • Our Approved Medicines
    • Guidance & Patient Support (U.S. Only)
    • Investigational Medicines (Pipeline)
    • Clinical Trials
    • Expanded Access
    • Become a Vertex Investigator
    • Independent Research
  • All In For CF
    • All In For CF
    • Understanding CF
    • Voices of CF
    • Our Advances in CF
    • Vertex in the CF Community
    • CF Community Support
  • Giving Back
    • Giving Back
    • Our STEM Program
    • Volunteer Programs
    • Grants & Funding Opportunities
    • Cystic Fibrosis Programs
    • The Vertex Foundation
  • Working Here
    • Working Here
    • Join Our Team
    • Employee Benefits
    • Rewards & Recognition
    • Career Development
    • University Relations
    • Diversity & Inclusion
  • Investors
  • Contact Us
  • Press Releases

You are here

  • Home
  • Home
  • Investors

    • Investor Relations

    Investor Relations

    • Investors Home
    • News & Events
      • Press Releases
      • Events & Presentations
    • Stock Information
      • Quote & Chart
      • Historic Stock Lookup
      • Investment Calculator
    • Analyst Coverage
    • Financial Information
      • Quarterly Results
      • SEC Filings
    • Corporate Governance
      • Governance Documents
      • Leadership
      • Board of Directors
    • Investor Resources
      • IR Contacts
      • FAQs
      • Approved Medicines
      • Pipeline
    • MENU

      Investor Relations

      • Investors Home
      • News & Events
        • Press Releases
        • Events & Presentations
      • Stock Information
        • Quote & Chart
        • Historic Stock Lookup
        • Investment Calculator
      • Analyst Coverage
      • Financial Information
        • Quarterly Results
        • SEC Filings
      • Corporate Governance
        • Governance Documents
        • Leadership
        • Board of Directors
      • Investor Resources
        • IR Contacts
        • FAQs
        • Approved Medicines
        • Pipeline

    Vertex Pharmaceuticals First Quarter 2018 Earnings Conference Call

    Apr 26, 2018 at 4:30 PM EDT

    Listen to webcast
    View Presentatrion 1.6 MB
    ×
    The Science of possibility

    The Science of Possibility

    Vertex creates new possibilities in medicine to cure diseases and improve people's lives. We work with leading researchers, doctors, public health experts and other collaborators who share our vision for transforming the lives of people with serious diseases, their families and society.

    Locations

    Corporate Headquarters
    50 Northern Avenue
    Boston, MA 02210
    Tel +1(617)-341-6100

    • Global Locations

    Join Us

    • Working Here
    • Current Openings
    • Internships

    Giving Back

    • Our STEM Program
    • Volunteer Programs
    • Grants & Funding
    • Privacy  
    • Terms of Use
    • Compliance Program
    • Transparency
    • LinkedIn
    • Twitter

    KALYDECO, the KALYDECO logo, ORKAMBI, the ORKAMBI logo, Vertex and the Vertex triangle logo are registered trademarks of Vertex Pharmaceuticals Incorporated.
    SYMDEKO and the SYMDEKO logo are trademarks of Vertex Pharmaceuticals Incorporated.
    All other trademarks referenced herein are the properties of their respective owners.

    © 2017 Vertex Pharmaceuticals Incorporated | VXR-US-00-00270 | 04/2017